Related Experiment Video
Updated: Apr 24, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
In vitro combination of voriconazole and miltefosine against clinically relevant molds
S Imbert1, M Palous1, I Meyer1
1AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
Abstract:
Invasive infections caused by filamentous fungi are a major threat for immunocompromised patients. Innate/acquired resistance to antifungal drugs might necessitate combination therapies. We assessed the potential combination of voriconazole with miltefosine, an original drug with antifungal activity against 33 clinically relevant mold isolates, including both azole-susceptible and -resistant Aspergillus. Using complete inhibition as an endpoint, interactions were indifferent for 32/33 isolates. An alternative 50% inhibition endpoint showed synergistic interactions for 14/33 isolates. Antagonism was absent.
Insights
Voriconazole combined with miltefosine showed synergistic antifungal activity against some molds, particularly at a 50% inhibition threshold. This combination may offer new therapeutic options for invasive fungal infections in immunocompromised patients.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pharmacology
Background:
- Invasive filamentous fungal infections pose a significant risk to immunocompromised individuals.
- Antifungal resistance necessitates exploring novel combination therapies.
Purpose of the Study:
- To evaluate the in vitro synergistic potential of voriconazole and miltefosine against clinically relevant mold isolates.
- To assess antifungal interactions against both azole-susceptible and -resistant Aspergillus species.
Main Methods:
- Tested the combination of voriconazole and miltefosine against 33 mold isolates.
- Assessed drug interactions using complete inhibition and 50% inhibition endpoints.
Main Results:
- Interactions were predominantly indifferent (32/33 isolates) when using complete inhibition as the endpoint.
- Synergistic interactions were observed for 14/33 isolates using a 50% inhibition endpoint.
- No antagonistic effects were detected between the two drugs.
Conclusions:
- The combination of voriconazole and miltefosine demonstrates potential for synergistic activity against certain molds, especially at a reduced inhibition threshold.
- This combination warrants further investigation as a potential treatment strategy for invasive fungal infections.
Related Concept Videos
Antifungal Agents
Antimicrobial Effectiveness
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Fungal Group Zygomycota
Fungal Phylum Microsporidia

